Dongsheng Pharma (GREY:DNGH)

Wednesday, July 27, 2011 | Web News
In consideration of recent market conditions and costs associated with being a public company, the Board of Directors of Dongsheng Pharmaceutical International Co., Ltd. (the...
Thursday, May 26, 2011 | Web News
Over the next twelve months, we intend to pursue our primary objectives of increasing market share in China and diversifying our product lines. We are also evaluating acquisition...
Thursday, May 26, 2011 | Web News
> During the nine months ended March 31, 2011, we took significant steps in our efforts to diversify our product portfolio and revenue sources....
See All Research...

At least one FIE exists in the corporate structure

DBL, through Xintai, is a pharmaceutical wholesale company in the PRC. Xintai was incorporated in 1999 as a small pharmaceutical sales company. On July 15th, 2006, Zhu Xiaodong and Zhu Xiaomei acquired 100% of Xintai for approximately $250,973. Xintai soon became a well-known licensed pharmaceutical wholesale company, specializing in the sales of prescription and OTC medicines. Xintai is also involved in research and development (R&D) of new drugs and medicine registration fields.

Last updated May 1, 2010


Market Data powered by QuoteMedia. Terms of Use